Digital Histopathology and Microdissection
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 4 of these applications claim priority to application 62/557,737, filed Sep 12, 2017. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Patent lifetimeUsedRemaining | Confidence |
|---|---|---|---|---|---|---|
| US 12,002,262 | Digital Histopathology and Microdissection In force · Medium confidence UsedRemaining | Nantomics, LLC | In force | Medium confidence | ||
| US 10,769,788 | Few-Shot Learning Based Image Recognition of Whole Slide Image at Tissue Level In force · Medium confidence | Nantomics, LLC | In force | Medium confidence | ||
| US 10,607,343 | Digital Histopathology and Microdissection In force · High confidence | Nantomics, LLC | In force | High confidence | ||
| US 11,682,195 | Digital Histopathology and Microdissection In force · High confidence | Nantomics, LLC | In force | High confidence | ||
| Application 18/645,309 | Digital Histopathology and Microdissection Pending Not granted | Nantomics, LLC | Pending | Not granted |
5 of 5 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
4 of these are in force and held by Nantomics, LLC.
Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.